This topic contains a solution. Click here to go to the answer

Author Question: The client who has received intravenous immune globulin must wait what length of time before ... (Read 117 times)

tingc95

  • Hero Member
  • *****
  • Posts: 556
The client who has received intravenous immune globulin must wait what length of time before receiving active immunization?
 
  1. 2 months
  2. 1 year
  3. 4 months
  4. 1 month

Question 2

The nurse correctly understands that the administration of the PCV vaccine should occur at which ages?
 
  1. 5 and 10 months
  2. 15 and 18 months
  3. 1, 8, 13, and 18 to 20 months
  4. 2, 4, 6, and 12 to 15 months



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

bhavsar

  • Sr. Member
  • ****
  • Posts: 351
Answer to Question 1

Correct Answer: 3
Rationale 1: Two months is not long enough.
Rationale 2: One year is too long to wait for additional immunizations.
Rationale 3: The client must wait at least 3 to 5 months.
Rationale 4: One month is not long enough.
Global Rationale: Because this drug contains antibodies to live viruses, active vaccinations should not be given until 3 to 5 months after IVIG has been administered.

Answer to Question 2

Correct Answer: 4
Rationale 1: This is not the time frame for PCV administration.
Rationale 2: This is not the time frame for PCV administration.
Rationale 3: This is not the time frame for PCV administration.
Rationale 4: The PCV vaccine should be administered at 2, 4, 6, and 12 to 15 months.
Global Rationale: Because the administration of PPV to young children with immature immune systems leads to a poor antibody response, this vaccine is not recommended in children under 2 years of age. A second vaccine, called pneumococcal conjugate vaccine (PCV), was specially developed for routine immunization in children under the age of 2. This immunization differs from PPV in that the S. pneumoniae polysaccharides are coupled with a protein that leads to improved immune activation in infants with immature immune function. The latest form of the pneumococcal conjugate vaccine, PCV13, was approved in 2010 and protects against 13 types of pneumococcal bacteria. PCV13 is used in a series of four IM injections at 2 months, 4 months, 6 months, and 12 to 15 months.




tingc95

  • Member
  • Posts: 556
Reply 2 on: Jul 23, 2018
Excellent


tkempin

  • Member
  • Posts: 332
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Astigmatism is the most common vision problem. It may accompany nearsightedness or farsightedness. It is usually caused by an irregularly shaped cornea, but sometimes it is the result of an irregularly shaped lens. Either type can be corrected by eyeglasses, contact lenses, or refractive surgery.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

People about to have surgery must tell their health care providers about all supplements they take.

Did you know?

Multiple experimental evidences have confirmed that at the molecular level, cancer is caused by lesions in cellular DNA.

Did you know?

The toxic levels for lithium carbonate are close to the therapeutic levels. Signs of toxicity include fine hand tremor, polyuria, mild thirst, nausea, general discomfort, diarrhea, vomiting, drowsiness, muscular weakness, lack of coordination, ataxia, giddiness, tinnitus, and blurred vision.

For a complete list of videos, visit our video library